Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Discovery Genomics Inc.

This article was originally published in Start Up

Executive Summary

Discovery Genomics Inc.'s Sleeping Beauty transposon vector is non-viral, but it can integrate into the genome to achieve long-term expression. DGI uses it in two parts: the transposon vector carries the therapeutic genes, and the transposase enzyme moves it from the vector into the chromosome. When delivered to cells at the same time, the transposase cuts the therapeutic gene out of the vector and inserts it into the host chromosome, much like you cut and paste using a word processor.


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts